About Aaron Missere
Aaron Missere is the CEO and founder of financial media company Departures Capital Inc. He is an avid and experienced investor, with a primary focus on the cannabis industry. In addition to being a featured contributor to StockNews.com and ETFDailyNews.com, he is an author for SmarterAnalyst.com. Aaron also currently hosts a weekly show on YouTube that recaps and explains the movement in the stock market, with a heavy emphasis on marijuana stocks.
Recent Articles By Aaron Missere
Why Did an Analyst Raise His Price Target on Aurora Cannabis Yesterday?
Yesterday Aurora Cannabis (ACB) provided a corporate update that focused on its business transformation plan that was announced to investors back in February
Is Aurora Cannabis a Buy or a Sell?
It's been a rollercoaster ride for shareholders of Aurora Cannabis (ACB) since they announced their 12:1 reverse stock split last month
Will Innovative Industrial Properties Continue to Rally?
It seems as if nothing is going to stop Innovative Industrial Properties (IIPR) from hitting triple-digit prices again
Marijuana Stocks Weekly Recap
This week in the Marijuana Weekly Recap, we report on news released from Aurora Cannabis (ACB) and HEXO (HEXO), and update readers on GW Pharmaceuticals (GWPH)
Why are Shares of HEXO Trading Down More Than 20% This Week?
Yesterday HEXO plummeted after announcing a C$34.5 million ($25.5 million) at-the-market stock offering program
Is an Announcement of a New CEO at Aurora Cannabis Imminent?
On Tuesday of this week, Aurora Cannabis (ACB) announced that Co-Founder Steve Dobler will retire from his roles as President and Director of the Company
Are Shares of Aphria a Buy at the Current Price?
For the first time since the global coronavirus pandemic began, Aphria (APHA) traded above $5 last week
Cannabis Stocks Weekly Recap
In this week's recap we are discussing Aurora Cannabis (ACB), HEXO Corp. (HEXO), Akerna (KERN), and Aphria (APHA)
OrganiGram Announces a New International Agreement
It's been a tough year for OrganiGram (OGI). 12 months ago OGI was trading over $7 per share but as the cannabis sector declined and the COVID-19 pandemic hit the market, the stock sank to lows of almost $1